Tricida Inc (Tricida) is a clinical-stage pharmaceutical and drug discovery company. The company discovers and develops novel non-absorbed therapies for the treatment of renal, metabolic and cardiovascular diseases. Its lead drug candidate TRC101 is under clinical development to treat metabolic acidosis a common complication of chronic kidney disease (CKD). Tricida plans to initiate a Phase 3 study to evaluate the safety and efficacy of TRC101 as a potential treatment for chronic metabolic acidosis associated with CKD. The company is also conducting clinical trials on VALOR-CKD (TRCA-303). The company’s portfolio of investors includes OrbiMed, Sibling Capital and Longitude Capital. Tricida is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
7000 Shoreline Court, Suite 201, South San Francisco, California, 94080
Website
www.tricida.com
Telephone
1 415 4297800
No of Employees
57
Industry
Pharmaceuticals and Healthcare
Tricida Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| TRC101 : |
| Chronic Kidney Disease |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Tricida Inc | AstraZeneca Plc | Marinus Pharmaceuticals Inc | Cartesian Therapeutics Inc | BioAegis Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United Kingdom | United States of America | United States of America | United States of America |
| City | South San Francisco | Cambridge | Radnor | Watertown | Morristown |
| State/Province | California | England | Pennsylvania | Massachusetts | New Jersey |
| No. of Employees | 57 | 89,900 | 165 | 38 | 12 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Klaus R. Veitinger | Chairman | Executive Board | 2015 | 59 |
| Gerrit Klaerner, Ph.D. | President; Director; Chief Executive Officer | Executive Board | 2013 | 51 |
| Geoffrey M. Parker | Chief Financial Officer; Executive Vice President | Senior Management | 2017 | 57 |
| Wilhelm Stahl, Ph.D. | Executive Vice President; Chief Technology Officer | Senior Management | 2017 | - |
| Robert McKague | Executive Vice President; Chief Compliance Officer; General Counsel | Senior Management | 2020 | 58 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward